首页 > 最新文献

Journal of Clinical Tuberculosis and Other Mycobacterial Diseases最新文献

英文 中文
Mycobacterium tuberculosis evolution from monoresistance to pre-extensive drug resistance during a prolonged household outbreak 在一次长期家庭疫情中,结核分枝杆菌从单一抗药性进化到前期广泛抗药性
IF 1.9 Q3 INFECTIOUS DISEASES Pub Date : 2024-10-14 DOI: 10.1016/j.jctube.2024.100482
G. Greif , C. Coithino , M.N. Bentancor , C. Robello
Whole genome sequencing (WGS) is sensitive tool for the analysis of tuberculosis transmission and drug-resistance. We used WGS to analyze the Mycobacterium tuberculosis evolution from isoniazid monoresistance to MDR/preXDR during a prolonged household outbreak. The outbreak started with a isoniazid resistant strain (katG S315T mutation) and evolve in two cases to pre-XDR phenotype (with mutations in katG, rpoB, embB, pncA and gyrA genes). Based on WGS data and epidemiological interview we proposed a possible chain of transmission an evolution of the strains.
Similar intra-patient and inter-patient acquisition of variability was observed, making difficult to distinguish reinfection or reactivation. Analysis of WGS data together with epidemiological clinical history are discussed in order to distinguish between prolonged infections or transition from latency to reactivation. Classical interview and clinical history taking should be consider to fully understanding WGS data. With a still low incidence of TB cases, Uruguay could use universal WGS of all isolates to reduce time of diagnosis, detect outbreaks and perform public actions to reduce TB incidence.
全基因组测序(WGS)是分析结核病传播和耐药性的灵敏工具。我们利用 WGS 分析了在一次长期家庭疫情中结核分枝杆菌从异烟肼单耐药到 MDR/preXDR 的演变过程。疫情始于耐异烟肼菌株(katG S315T 突变),并在两个病例中演变为前 XDR 表型(katG、rpoB、embB、pncA 和 gyrA 基因突变)。根据 WGS 数据和流行病学访谈,我们提出了菌株可能的传播链和演变过程。我们对 WGS 数据分析和流行病学临床病史进行了讨论,以区分是长期感染还是从潜伏期过渡到再激活。要充分理解 WGS 数据,应考虑传统的访谈和临床病史采集。在结核病发病率仍然较低的情况下,乌拉圭可以利用对所有分离菌株进行普遍的 WGS 检测来缩短诊断时间、发现疫情爆发并采取公共行动降低结核病发病率。
{"title":"Mycobacterium tuberculosis evolution from monoresistance to pre-extensive drug resistance during a prolonged household outbreak","authors":"G. Greif ,&nbsp;C. Coithino ,&nbsp;M.N. Bentancor ,&nbsp;C. Robello","doi":"10.1016/j.jctube.2024.100482","DOIUrl":"10.1016/j.jctube.2024.100482","url":null,"abstract":"<div><div>Whole genome sequencing (WGS) is sensitive tool for the analysis of tuberculosis transmission and drug-resistance. We used WGS to analyze the <em>Mycobacterium tuberculosis</em> evolution from isoniazid monoresistance to MDR/preXDR during a prolonged household outbreak. The outbreak started with a isoniazid resistant strain (katG S315T mutation) and evolve in two cases to pre-XDR phenotype (with mutations in katG, rpoB, embB, pncA and gyrA genes). Based on WGS data and epidemiological interview we proposed a possible chain of transmission an evolution of the strains.</div><div>Similar intra-patient and inter-patient acquisition of variability was observed, making difficult to distinguish reinfection or reactivation. Analysis of WGS data together with epidemiological clinical history are discussed in order to distinguish between prolonged infections or transition from latency to reactivation. Classical interview and clinical history taking should be consider to fully understanding WGS data. With a still low incidence of TB cases, Uruguay could use universal WGS of all isolates to reduce time of diagnosis, detect outbreaks and perform public actions to reduce TB incidence.</div></div>","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"37 ","pages":"Article 100482"},"PeriodicalIF":1.9,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142446422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment outcomes among patients with isoniazid mono-resistant tuberculosis in Mumbai, India: A retrospective cohort study 印度孟买单耐药异烟肼结核病患者的治疗结果:回顾性队列研究
IF 1.9 Q3 INFECTIOUS DISEASES Pub Date : 2024-10-12 DOI: 10.1016/j.jctube.2024.100481
Sumaiya Khan , Arunima Silsarma , Raman Mahajan , Shahid Khan , Praveen Davuluri , Narendra Sutar , Aparna Iyer , Shubhangi Mankar , Vikas Oswal , Varsha Puri , Daksha Shah , Vijay Chavan , Hannah Spencer , Petros Isaakidis

Background

Tuberculosis (TB) remains a significant cause of mortality globally, with India accounting for 27% of the estimated number of people with TB. Multidrug-resistant TB (MDR-TB) and isoniazid (INH) resistance pose additional challenges to effective treatment. We aimed to describe treatment outcomes of INH mono-resistant TB patients under programmatic conditions in Mumbai, India.

Methods

This retrospective cohort study was conducted at Shatabdi Hospital in Mumbai between 2019–2021.We described the clinical and demographic characteristics, treatment outcomes, and risk factors for unfavourable outcomes among patients with INH mono-resistant TB treated with rifampicin, ethambutol, pyrazinamide, and levofloxacin (LfxREZ) for a duration of 6 months.

Results

Among 3105 patients with drug-resistant TB initiated on treatment, 217 (7 %) had INH mono-resistant TB. Of these, 54 % (117/217) were female, with a median age of 26 years (interquartile range: 20–40). The majority (88 %; 191/217) presented with pulmonary TB, and most (87 %; 188/217) had favourable treatment outcomes, including treatment completion (52 %; 112/217) and cure (35 %; 76/217). Unfavourable outcomes, including treatment failure (2.3 %; 5/217), loss to follow-up (9.2 %; 20/217), or death (1.8 %; 4/217), were observed in 13 % (29/217) of patients. A total of ten (5 %) patients experienced at least one non-severe adverse drug reaction. Factors associated with unfavourable outcomes included severe thinness (p = 0.019) and male gender (p = 0.012).

Conclusion

Treating INH mono-resistant patients with LfxREZ resulted in satisfactory outcomes and low toxicity. It is important to rule out drug resistance to INH while determining the treatment regimen.
背景肺结核(TB)仍然是全球死亡的一个重要原因,印度占肺结核患者估计人数的 27%。耐多药结核病(MDR-TB)和异烟肼(INH)耐药性给有效治疗带来了更多挑战。我们旨在描述印度孟买计划条件下 INH 单耐药肺结核患者的治疗结果。方法这项回顾性队列研究于 2019-2021 年间在孟买 Shatabdi 医院进行。我们描述了接受利福平、乙胺丁醇、吡嗪酰胺和左氧氟沙星(LfxREZ)治疗 6 个月的 INH 单耐药肺结核患者的临床和人口统计学特征、治疗结果和不利结果的风险因素。结果在 3105 名开始接受治疗的耐药肺结核患者中,217 人(7%)为 INH 单耐药肺结核。其中,54%(117/217)为女性,中位年龄为 26 岁(四分位数间距:20-40)。大多数患者(88%;191/217)表现为肺结核,大多数患者(87%;188/217)的治疗结果良好,包括完成治疗(52%;112/217)和治愈(35%;76/217)。13%的患者(29/217)出现了不利的结果,包括治疗失败(2.3%;5/217)、失去随访(9.2%;20/217)或死亡(1.8%;4/217)。共有 10 名患者(5%)至少出现过一次非严重药物不良反应。与不良反应相关的因素包括严重消瘦(p = 0.019)和男性(p = 0.012)。结论用 LfxREZ 治疗 INH 单耐药患者的疗效令人满意,且毒性较低。在确定治疗方案时,必须排除 INH 的耐药性。
{"title":"Treatment outcomes among patients with isoniazid mono-resistant tuberculosis in Mumbai, India: A retrospective cohort study","authors":"Sumaiya Khan ,&nbsp;Arunima Silsarma ,&nbsp;Raman Mahajan ,&nbsp;Shahid Khan ,&nbsp;Praveen Davuluri ,&nbsp;Narendra Sutar ,&nbsp;Aparna Iyer ,&nbsp;Shubhangi Mankar ,&nbsp;Vikas Oswal ,&nbsp;Varsha Puri ,&nbsp;Daksha Shah ,&nbsp;Vijay Chavan ,&nbsp;Hannah Spencer ,&nbsp;Petros Isaakidis","doi":"10.1016/j.jctube.2024.100481","DOIUrl":"10.1016/j.jctube.2024.100481","url":null,"abstract":"<div><h3>Background</h3><div>Tuberculosis (TB) remains a significant cause of mortality globally, with India accounting for 27% of the estimated number of people with TB. Multidrug-resistant TB (MDR-TB) and isoniazid (INH) resistance pose additional challenges to effective treatment. We aimed to describe treatment outcomes of INH mono-resistant TB patients under programmatic conditions in Mumbai, India.</div></div><div><h3>Methods</h3><div>This retrospective cohort study was conducted at Shatabdi Hospital in Mumbai between 2019–2021.We described the clinical and demographic characteristics, treatment outcomes, and risk factors for unfavourable outcomes among patients with INH mono-resistant TB treated with rifampicin, ethambutol, pyrazinamide, and levofloxacin (LfxREZ) for a duration of 6 months.</div></div><div><h3>Results</h3><div>Among 3105 patients with drug-resistant TB initiated on treatment, 217 (7 %) had INH mono-resistant TB. Of these, 54 % (117/217) were female, with a median age of 26 years (interquartile range: 20–40). The majority (88 %; 191/217) presented with pulmonary TB, and most (87 %; 188/217) had favourable treatment outcomes, including treatment completion (52 %; 112/217) and cure (35 %; 76/217). Unfavourable outcomes, including treatment failure (2.3 %; 5/217), loss to follow-up (9.2 %; 20/217), or death (1.8 %; 4/217), were observed in 13 % (29/217) of patients. A total of ten (5 %) patients experienced at least one non-severe adverse drug reaction. Factors associated with unfavourable outcomes included severe thinness (p = 0.019) and male gender (p = 0.012).</div></div><div><h3>Conclusion</h3><div>Treating INH mono-resistant patients with LfxREZ resulted in satisfactory outcomes and low toxicity. It is important to rule out drug resistance to INH while determining the treatment regimen.</div></div>","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"37 ","pages":"Article 100481"},"PeriodicalIF":1.9,"publicationDate":"2024-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142446424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiology of nontuberculous mycobacteria in the Finger Lakes region of New York 纽约手指湖地区的非结核分枝杆菌流行病学
IF 1.9 Q3 INFECTIOUS DISEASES Pub Date : 2024-10-11 DOI: 10.1016/j.jctube.2024.100483
Michael Croix , Ghinwa Dumyati , Alexandra Adams , Paul Levy , Emil Lesho , Dwight Hardy , Sonal Munsiff
Clinical-epidemiologic data for all nontuberculous mycobacteria isolated in the 9 County Finger Lakes region of NY from 226 patients between 04/01/2018–03/31/2020 were retrospectively analyzed. Only 51% of patients meeting diagnostic criteria were treated, while 25% not meeting diagnostic criteria were also treated, indicating important knowledge gaps and research opportunities.
我们对纽约州五指湖 9 县地区 226 名患者在 2018 年 4 月 1 日至 2020 年 3 月 31 日期间分离出的所有非结核分枝杆菌的临床流行病学数据进行了回顾性分析。只有 51% 符合诊断标准的患者接受了治疗,而 25% 不符合诊断标准的患者也接受了治疗,这表明存在重要的知识差距和研究机会。
{"title":"Epidemiology of nontuberculous mycobacteria in the Finger Lakes region of New York","authors":"Michael Croix ,&nbsp;Ghinwa Dumyati ,&nbsp;Alexandra Adams ,&nbsp;Paul Levy ,&nbsp;Emil Lesho ,&nbsp;Dwight Hardy ,&nbsp;Sonal Munsiff","doi":"10.1016/j.jctube.2024.100483","DOIUrl":"10.1016/j.jctube.2024.100483","url":null,"abstract":"<div><div>Clinical-epidemiologic data for all nontuberculous mycobacteria isolated in the 9 County Finger Lakes region of NY from 226 patients between 04/01/2018–03/31/2020 were retrospectively analyzed. Only 51% of patients meeting diagnostic criteria were treated, while 25% not meeting diagnostic criteria were also treated, indicating important knowledge gaps and research opportunities.</div></div>","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"37 ","pages":"Article 100483"},"PeriodicalIF":1.9,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142432864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tuberculosis in South Asia: A regional analysis of burden, progress, and future projections using the global burden of disease (1990–2021) 南亚的结核病:利用全球疾病负担(1990-2021 年)对负担、进展和未来预测进行区域分析
IF 1.9 Q3 INFECTIOUS DISEASES Pub Date : 2024-10-08 DOI: 10.1016/j.jctube.2024.100480
Vijay Kumar , Mahalaqua Nazli Khatib , Amit Verma , Sorabh Lakhanpal , Suhas Ballal , Sanjay Kumar , Mahakshit Bhat , Aryantika Sharma , M. Ravi Kumar , Aashna Sinha , Abhay M. Gaidhane , Muhammed Shabil , Mahendra Pratap Singh , Sanjit Sah , Kiran Bhopte , Kamal Kundra , Shailesh Kumar Samal

Background

Tuberculosis (TB) is a major public health issue in South Asia and accounts for a large share of the global TB burden. Despite global efforts to curb TB incidence and mortality, progress in South Asia has been uneven, necessitating focused regional analysis to guide effective interventions. This study aims to analyse the trends in the TB burden in South Asia from 1990 to 2021 and project future TB incidence rates up to 2031.

Methods

This study utilized data from the Global Burden of Disease (GBD) 2021 results to analyse trends in age-standardized incidence (ASIR), prevalence (ASPR), mortality (ASMR), and disability-adjusted life years (DALYs) rates (ASDR) associated with TB in South Asia from 1990 to 2021. Joinpoint regression analysis was employed to identify significant trends, whereas ARIMA models were used to project future TB incidence rates up to 2031.

Results

This study revealed significant declines in the ASIR, ASPR, ASDR, and ASMR related to TB in South Asia over the past three decades. Prominent reductions were found in Bangladesh and Bhutan, whereas India, Pakistan, and Nepal continue to bear the highest TB burdens. The ARIMA model projections indicate a continued decline in TB incidence across the region, although the extent of the decline varies by country, with less favourable trends observed in Nepal and Pakistan. The analysis also highlights tobacco use, high fasting plasma glucose, and high body mass index as significant risk factors contributing to the TB burden.

Conclusions

Substantial progress has been made in reducing the TB burden in South Asia; however, sustained and intensified efforts are needed, particularly in countries with inconsistent progress. These findings emphasize the need for targeted interventions to meet the WHO End TB Strategy (WETS) targets by 2035. Continuous monitoring and adaptive strategies will be crucial in maintaining and accelerating progress toward TB elimination in South Asia.
背景结核病(TB)是南亚的一个主要公共卫生问题,在全球结核病负担中占很大比例。尽管全球都在努力遏制结核病的发病率和死亡率,但南亚地区的进展并不均衡,因此有必要进行重点区域分析,以指导采取有效的干预措施。本研究旨在分析 1990 年至 2021 年南亚地区的结核病负担趋势,并预测未来至 2031 年的结核病发病率。本研究利用 2021 年全球疾病负担(GBD)结果中的数据,分析 1990 年至 2021 年南亚地区与结核病相关的年龄标准化发病率(ASIR)、流行率(ASPR)、死亡率(ASMR)和残疾调整生命年(DALYs)率(ASDR)的趋势。这项研究显示,在过去三十年中,南亚与结核病相关的 ASIR、ASPR、ASDR 和 ASMR 显著下降。孟加拉国和不丹的发病率明显下降,而印度、巴基斯坦和尼泊尔的结核病负担仍然最高。ARIMA 模型预测表明,整个地区的肺结核发病率将继续下降,但各国的下降程度不同,尼泊尔和巴基斯坦的趋势较弱。分析还强调,吸烟、空腹血浆葡萄糖过高和体重指数过高是造成结核病负担的重要风险因素。这些发现强调,需要采取有针对性的干预措施,以实现世界卫生组织到 2035 年终结结核病战略 (WETS) 的目标。持续监测和适应性战略对于保持和加快南亚消除结核病的进展至关重要。
{"title":"Tuberculosis in South Asia: A regional analysis of burden, progress, and future projections using the global burden of disease (1990–2021)","authors":"Vijay Kumar ,&nbsp;Mahalaqua Nazli Khatib ,&nbsp;Amit Verma ,&nbsp;Sorabh Lakhanpal ,&nbsp;Suhas Ballal ,&nbsp;Sanjay Kumar ,&nbsp;Mahakshit Bhat ,&nbsp;Aryantika Sharma ,&nbsp;M. Ravi Kumar ,&nbsp;Aashna Sinha ,&nbsp;Abhay M. Gaidhane ,&nbsp;Muhammed Shabil ,&nbsp;Mahendra Pratap Singh ,&nbsp;Sanjit Sah ,&nbsp;Kiran Bhopte ,&nbsp;Kamal Kundra ,&nbsp;Shailesh Kumar Samal","doi":"10.1016/j.jctube.2024.100480","DOIUrl":"10.1016/j.jctube.2024.100480","url":null,"abstract":"<div><h3>Background</h3><div>Tuberculosis (TB) is a major public health issue in South Asia and accounts for a large share of the global TB burden. Despite global efforts to curb TB incidence and mortality, progress in South Asia has been uneven, necessitating focused regional analysis to guide effective interventions. This study aims to analyse the trends in the TB burden in South Asia from 1990 to 2021 and project future TB incidence rates up to 2031.</div></div><div><h3>Methods</h3><div>This study utilized data from the Global Burden of Disease (GBD) 2021 results to analyse trends in age-standardized incidence (ASIR), prevalence (ASPR), mortality (ASMR), and disability-adjusted life years (DALYs) rates (ASDR) associated with TB in South Asia from 1990 to 2021. Joinpoint regression analysis was employed to identify significant trends, whereas ARIMA models were used to project future TB incidence rates up to 2031.</div></div><div><h3>Results</h3><div>This study revealed significant declines in the ASIR, ASPR, ASDR, and ASMR related to TB in South Asia over the past three decades. Prominent reductions were found in Bangladesh and Bhutan, whereas India, Pakistan, and Nepal continue to bear the highest TB burdens. The ARIMA model projections indicate a continued decline in TB incidence across the region, although the extent of the decline varies by country, with less favourable trends observed in Nepal and Pakistan. The analysis also highlights tobacco use, high fasting plasma glucose, and high body mass index as significant risk factors contributing to the TB burden.</div></div><div><h3>Conclusions</h3><div>Substantial progress has been made in reducing the TB burden in South Asia; however, sustained and intensified efforts are needed, particularly in countries with inconsistent progress. These findings emphasize the need for targeted interventions to meet the WHO End TB Strategy (WETS) targets by 2035. Continuous monitoring and adaptive strategies will be crucial in maintaining and accelerating progress toward TB elimination in South Asia.</div></div>","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"37 ","pages":"Article 100480"},"PeriodicalIF":1.9,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142528132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mycobacterium heraklionense: An emerging cause of hand tenosynovitis 赫氏分枝杆菌:手部腱鞘炎的新病因
IF 1.9 Q3 INFECTIOUS DISEASES Pub Date : 2024-09-27 DOI: 10.1016/j.jctube.2024.100479
Majdouline El Moussaoui , Nicolas Lambert , Patrick Massage , Cécile Meex , Marie-Pierre Hayette , Philippe Delvenne , Charline Rinkin , Michel Moutschen , Gilles Darcis , Olivier Malaise , Jean-Baptiste Giot
Misdiagnosis of Mycobacterium heraklionense tenosynovitis is common due to the challenging identification and perceived rarity of the disease. This can result in delayed therapy initiation and potentially irreversible consequences. In this report, we present an additional case of hand tenosynovitis, which highlights the diagnostic and management challenges of Mycobacterium heraklionense tenosynovitis and provides further evidence of its emergence as a cause of tenosynovitis. Additionally, we provide a comprehensive summary of published case reports that describe Mycobacterium heraklionense tenosynovitis.
由于腱鞘炎分枝杆菌的识别难度很大,而且人们认为这种疾病很罕见,因此这种疾病经常被误诊。这可能导致治疗启动延迟,并可能造成不可逆转的后果。在本报告中,我们又介绍了一例手部腱鞘炎病例,该病例凸显了疱状分枝杆菌腱鞘炎在诊断和治疗方面的挑战,并进一步证明了疱状分枝杆菌已成为腱鞘炎的病因之一。此外,我们还对已发表的描述 heraklionense 分枝杆菌腱鞘炎的病例报告进行了全面总结。
{"title":"Mycobacterium heraklionense: An emerging cause of hand tenosynovitis","authors":"Majdouline El Moussaoui ,&nbsp;Nicolas Lambert ,&nbsp;Patrick Massage ,&nbsp;Cécile Meex ,&nbsp;Marie-Pierre Hayette ,&nbsp;Philippe Delvenne ,&nbsp;Charline Rinkin ,&nbsp;Michel Moutschen ,&nbsp;Gilles Darcis ,&nbsp;Olivier Malaise ,&nbsp;Jean-Baptiste Giot","doi":"10.1016/j.jctube.2024.100479","DOIUrl":"10.1016/j.jctube.2024.100479","url":null,"abstract":"<div><div>Misdiagnosis of <em>Mycobacterium heraklionense</em> tenosynovitis is common due to the challenging identification and perceived rarity of the disease. This can result in delayed therapy initiation and potentially irreversible consequences. In this report, we present an additional case of hand tenosynovitis, which highlights the diagnostic and management challenges of <em>Mycobacterium heraklionense</em> tenosynovitis and provides further evidence of its emergence as a cause of tenosynovitis. Additionally, we provide a comprehensive summary of published case reports that describe <em>Mycobacterium heraklionense</em> tenosynovitis.</div></div>","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"37 ","pages":"Article 100479"},"PeriodicalIF":1.9,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142357626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Isolation and identification of non-tuberculous mycobacteria from aquarium fish in Ilam, Iran 伊朗伊拉姆水族馆鱼类非结核分枝杆菌的分离和鉴定
IF 1.9 Q3 INFECTIOUS DISEASES Pub Date : 2024-08-19 DOI: 10.1016/j.jctube.2024.100478
Mohammad Yazdanmanesh, Keyvan Tadayon, Darya Bagherian Koshkghazi, Nader Mosavari

Non-tuberculous mycobacteria (NTM) are among the most important pathogens in wild, captive, marine, and freshwater fish species. So, it is important to consider fish as the primary source of infection for aquarium fish and humans. The present study analyzed the occurrence of NTM in aquarium fish in Ilam, west of Iran. In total, 50 samples of infected fish were collected from different aquariums. Following initial sample processing, sediment of each sample was inoculated into Lowenstein-Jensen and Herrold egg media. The positive colonies were investigated with, growth rate, pigmentation, colony morphology, niacin accumulation, nitrate reduction, catalase activity, urease activity, and arylsulfatase activity. Also, molecular identification was carried out by sequencing of heat shock protein 65 kD gene (hsp65) sequence analysis. According to our results, NTM were isolated from 13 samples (26%), comprising 6 (46.2%) rapid growing, and 7 (53.8%) slow growing mycobacteria. In addition, Mycobacterium marinum was the most common NTM isolated in ornamental fish, which is potentially dangerous for both fish and humans. In conclusion, the current study indicates that ornamental fish play a significant role as a source of NTM.

非结核分枝杆菌(NTM)是野生、人工饲养、海洋和淡水鱼类中最重要的病原体之一。因此,将鱼类视为水族鱼类和人类的主要传染源非常重要。本研究分析了伊朗西部伊拉姆地区水族鱼类中 NTM 的发生情况。总共从不同的水族馆收集了 50 个受感染鱼类样本。在对样本进行初步处理后,将每个样本的沉淀物接种到 Lowenstein-Jensen 和 Herrold 卵培养基中。对阳性菌落的生长速度、色素沉着、菌落形态、烟酸积累、硝酸盐还原、过氧化氢酶活性、脲酶活性和芳基硫酸酯酶活性进行了研究。此外,还通过热休克蛋白 65 kD 基因(hsp65)序列分析进行了分子鉴定。结果显示,从 13 个样本(26%)中分离出了非结核分枝杆菌,其中 6 个(46.2%)为快速生长分枝杆菌,7 个(53.8%)为慢速生长分枝杆菌。此外,海洋分枝杆菌是观赏鱼中最常见的非结核分枝杆菌,对鱼类和人类都有潜在危险。总之,目前的研究表明,观赏鱼是 NTM 的重要来源。
{"title":"Isolation and identification of non-tuberculous mycobacteria from aquarium fish in Ilam, Iran","authors":"Mohammad Yazdanmanesh,&nbsp;Keyvan Tadayon,&nbsp;Darya Bagherian Koshkghazi,&nbsp;Nader Mosavari","doi":"10.1016/j.jctube.2024.100478","DOIUrl":"10.1016/j.jctube.2024.100478","url":null,"abstract":"<div><p>Non-tuberculous mycobacteria (NTM) are among the most important pathogens in wild, captive, marine, and freshwater fish species. So, it is important to consider fish as the primary source of infection for aquarium fish and humans. The present study analyzed the occurrence of NTM in aquarium fish in Ilam, west of Iran. In total, 50 samples of infected fish were collected from different aquariums. Following initial sample processing, sediment of each sample was inoculated into Lowenstein-Jensen and Herrold egg media. The positive colonies were investigated with, growth rate, pigmentation, colony morphology, niacin accumulation, nitrate reduction, catalase activity, urease activity, and arylsulfatase activity. Also, molecular identification was carried out by sequencing of heat shock protein 65 kD gene (<em>hsp65</em>) sequence analysis. According to our results, NTM were isolated from 13 samples (26%), comprising 6 (46.2%) rapid growing, and 7 (53.8%) slow growing mycobacteria. In addition, <em>Mycobacterium marinum</em> was the most common NTM isolated in ornamental fish, which is potentially dangerous for both fish and humans. In conclusion, the current study indicates that ornamental fish play a significant role as a source of NTM.</p></div>","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"37 ","pages":"Article 100478"},"PeriodicalIF":1.9,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2405579424000652/pdfft?md5=b7bc321c40a22541121e5ed4e3017488&pid=1-s2.0-S2405579424000652-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142021445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intensive reprocessing of reusable bronchoscopes can reduce the false positive rate of Xpert MTB/RIF caused by nucleic acid residue 对可重复使用的支气管镜进行强化再处理可降低由核酸残留引起的 Xpert MTB/RIF 假阳性率
IF 1.9 Q3 INFECTIOUS DISEASES Pub Date : 2024-08-14 DOI: 10.1016/j.jctube.2024.100476
Xingxing Jin , Qianfang Hu , Yishi Li , Xia Zhang , Wan Tao , Houyu Zhong , Qinghai Zhao

Background/Purpose

Tuberculosis remains a leading cause of infectious death worldwide, The potential for nucleic acid residue on bronchoscopes to cause false positive results in molecular diagnostic methods and subsequently lead to tuberculosis misdiagnosis has long perplexed clinical.

Methods

We utilized Xpert MTB/RIF to analyze the liquid collected after bronchoscope washing, employed by patients either with or without active pulmonary tuberculosis, and subjected to standard reprocessing (SR) or intensive reprocessing (IR) procedures. The IR procedure included specialized training and the provision of patient information to cleaning staff before the SR procedure, and repeated washing and suction of the bronchoscope with sterilized water post SR procedure.

Results

55 participants enrolled in the study were divided into three groups: SR group (n = 28), IR group(n = 14), and the control group(n = 13). Among the 55 enrolled patients, neither Mycobacterium tuberculosis nor contamination was detected by MIGT 960 liquid culture in the washing liquid. The positive rate of MTB/RIF in the SR group (12/28) was significantly higher than that in the IR group (1/14), with a statistically significant difference observed between them (42.86 % vs. 7.14 %, P=0.018).

Conclusions

Nucleic acid residue on reusable bronchoscopes cleaned via the SR procedure was found to potentially cause false positives in MTB/RIF tests. Reprocessing bronchoscopes via the IR procedure was effective in significantly reducing nucleic acid residue, although complete elimination was not achieved.

长期以来,支气管镜上的核酸残留可能导致分子诊断方法出现假阳性结果,进而导致结核病误诊,这一直困扰着临床医生。方法我们利用Xpert MTB/RIF分析支气管镜清洗后收集的液体,这些液体由患有或不患有活动性肺结核的患者使用,并经过标准再处理(SR)或强化再处理(IR)程序。IR程序包括在SR程序前对清洁人员进行专门培训并提供患者信息,以及在SR程序后用消毒水反复清洗和抽吸支气管镜:结果55名参与研究者被分为三组:SR组(28人)、IR组(14人)和对照组(13人)。在 55 名入选患者中,通过 MIGT 960 液体培养,均未在清洗液中检测到结核分枝杆菌或污染。SR组的MTB/RIF阳性率(12/28)明显高于IR组(1/14),两者之间的差异有统计学意义(42.86 % vs. 7.14 %,P=0.018)。通过 IR 程序重新处理支气管镜能有效地显著减少核酸残留,但并不能完全消除核酸残留。
{"title":"Intensive reprocessing of reusable bronchoscopes can reduce the false positive rate of Xpert MTB/RIF caused by nucleic acid residue","authors":"Xingxing Jin ,&nbsp;Qianfang Hu ,&nbsp;Yishi Li ,&nbsp;Xia Zhang ,&nbsp;Wan Tao ,&nbsp;Houyu Zhong ,&nbsp;Qinghai Zhao","doi":"10.1016/j.jctube.2024.100476","DOIUrl":"10.1016/j.jctube.2024.100476","url":null,"abstract":"<div><h3>Background/Purpose</h3><p>Tuberculosis remains a leading cause of infectious death worldwide, The potential for nucleic acid residue on bronchoscopes to cause false positive results in molecular diagnostic methods and subsequently lead to tuberculosis misdiagnosis has long perplexed clinical.</p></div><div><h3>Methods</h3><p>We utilized Xpert MTB/RIF to analyze the liquid collected after bronchoscope washing, employed by patients either with or without active pulmonary tuberculosis, and subjected to standard reprocessing (SR) or intensive reprocessing (IR) procedures. The IR procedure included specialized training and the provision of patient information to cleaning staff before the SR procedure, and repeated washing and suction of the bronchoscope with sterilized water post SR procedure.</p></div><div><h3>Results</h3><p>55 participants enrolled in the study were divided into three groups: SR group (n = 28), IR group(n = 14), and the control group(n = 13). Among the 55 enrolled patients, neither Mycobacterium tuberculosis nor contamination was detected by MIGT 960 liquid culture in the washing liquid. The positive rate of MTB/RIF in the SR group (12/28) was significantly higher than that in the IR group (1/14), with a statistically significant difference observed between them (42.86 % vs. 7.14 %, P=0.018).</p></div><div><h3>Conclusions</h3><p>Nucleic acid residue on reusable bronchoscopes cleaned via the SR procedure was found to potentially cause false positives in MTB/RIF tests. Reprocessing bronchoscopes via the IR procedure was effective in significantly reducing nucleic acid residue, although complete elimination was not achieved.</p></div>","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"37 ","pages":"Article 100476"},"PeriodicalIF":1.9,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2405579424000639/pdfft?md5=3f8ddafd8f567849a17b648cc8c48070&pid=1-s2.0-S2405579424000639-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142162876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Malnutrition and unsuccessful tuberculosis treatment among people with multi-drug resistant tuberculosis in Uganda: A retrospective analysis 乌干达耐多药结核病患者的营养不良与结核病治疗失败:回顾性分析
IF 1.9 Q3 INFECTIOUS DISEASES Pub Date : 2024-08-12 DOI: 10.1016/j.jctube.2024.100477
Samuel Engoru , Francis Bajunirwe , Jonathan Izudi

Rationale

Multi-drug-resistant tuberculosis (MDR-TB) poses a significant public health challenge to the control and successful eradication of TB globally. Suboptimal treatment outcomes are common among persons with MDR-TB necessitating a need to understand the contextual factors.

Objective

We determined the factors associated with unsuccessful TB treatment among persons with MDR-TB at a large TB Unit in Central Uganda.

Methods

We retrospectively reviewed medical records for all persons with MDR-TB at Mubende Regional Referral Hospital MDR-TB Clinic in Central Uganda. The patients were treated with either second-line, modified second-line, or individualized anti-TB regimens and completed treatment between January 2012 and October 2023. The primary outcome was unsuccessful TB treatment defined as death, treatment failure, or loss to follow-up and measured as a binary outcome. We used a multivariable binary logistic regression analysis to determine the factors independently associated with unsuccessful TB treatment at a 5 % statistical significance level. We reported the adjusted odds ratio (aOR) and the 95 % confidence interval (CI).

Measurements and results

We analyzed data from 98 persons with MDR-TB who were aged 15–78 years (mean 36.4 ± 15.4 years). Of these, 40 (40.8 %) were cured, 25 (25.5 %) completed TB treatment, 1 (1.0 %) had treatment failure, 13 (13.3 %) died, and 19 (19.4 %) were lost to follow-up. Overall, 33 (33.7 %) participants had unsuccessful TB treatment which was associated with older age for a 1-year increase in age (aOR 1.05, 95 % CI 1.01–1.09), malnutrition—mid-upper arm circumference of <12.5 cm (aOR 2.99, 95 % CI 1.16–7.98), and previous TB treatment (aOR 0.28, 95 % CI 0.10–0.77).

Conclusion

Unsuccessful TB treatment is high among persons with MDR-TB at this TB Unit. It is more likely as age advances and when persons with MDR-TB have malnutrition, but less likely when they have been previously treated for TB. Therefore, interventions to improve treatment outcomes may be beneficial for persons with MDR-TB who are older, malnourished, and those newly diagnosed with the disease. For example, routine nutritional assessment and counseling, including nutritional support for malnourished persons with MDR-TB may be needed to optimize their TB treatment success.

理由耐多药结核病(MDR-TB)对全球控制和成功根除结核病构成了重大的公共卫生挑战。在 MDR-TB 患者中,治疗效果不理想的情况很常见,因此有必要了解其背景因素。方法我们回顾性地查阅了乌干达中部穆本德地区转诊医院 MDR-TB 诊所所有 MDR-TB 患者的医疗记录。这些患者接受了二线、改良二线或个体化抗结核治疗方案,并在 2012 年 1 月至 2023 年 10 月期间完成了治疗。主要结果是结核病治疗失败,定义为死亡、治疗失败或失去随访,以二元结果衡量。我们使用多变量二元逻辑回归分析来确定与结核病治疗不成功独立相关的因素,统计显著性水平为 5%。我们报告了调整后的几率比(aOR)和 95 % 的置信区间(CI)。其中,40 人(40.8%)治愈,25 人(25.5%)完成结核病治疗,1 人(1.0%)治疗失败,13 人(13.3%)死亡,19 人(19.4%)失去随访。总体而言,有 33 人(33.7%)的结核病治疗未获成功,而年龄每增加 1 岁就会增加(aOR 1.05,95 % CI 1.01-1.09),营养不良-中上臂围为 12.5 厘米(aOR 2.99,95 % CI 1.16-7.98),以及以前接受过结核病治疗(aOR 0.28,95 % CI 0.10-0.77)。随着年龄的增长和 MDR-TB 患者营养不良,治疗不成功的可能性更大,但如果他们以前接受过结核病治疗,则可能性较小。因此,对于年龄较大、营养不良和新确诊的 MDR-TB 患者来说,改善治疗效果的干预措施可能对他们有益。例如,可能需要进行常规营养评估和咨询,包括为营养不良的 MDR-TB 患者提供营养支持,以优化他们的结核病治疗效果。
{"title":"Malnutrition and unsuccessful tuberculosis treatment among people with multi-drug resistant tuberculosis in Uganda: A retrospective analysis","authors":"Samuel Engoru ,&nbsp;Francis Bajunirwe ,&nbsp;Jonathan Izudi","doi":"10.1016/j.jctube.2024.100477","DOIUrl":"10.1016/j.jctube.2024.100477","url":null,"abstract":"<div><h3>Rationale</h3><p>Multi-drug-resistant tuberculosis (MDR-TB) poses a significant public health challenge to the control and successful eradication of TB globally. Suboptimal treatment outcomes are common among persons with MDR-TB necessitating a need to understand the contextual factors.</p></div><div><h3>Objective</h3><p>We determined the factors associated with unsuccessful TB treatment among persons with MDR-TB at a large TB Unit in Central Uganda.</p></div><div><h3>Methods</h3><p>We retrospectively reviewed medical records for all persons with MDR-TB at Mubende Regional Referral Hospital MDR-TB Clinic in Central Uganda. The patients were treated with either second-line, modified second-line, or individualized anti-TB regimens and completed treatment between January 2012 and October 2023. The primary outcome was unsuccessful TB treatment defined as death, treatment failure, or loss to follow-up and measured as a binary outcome. We used a multivariable binary logistic regression analysis to determine the factors independently associated with unsuccessful TB treatment at a 5 % statistical significance level. We reported the adjusted odds ratio (aOR) and the 95 % confidence interval (CI).</p></div><div><h3>Measurements and results</h3><p>We analyzed data from 98 persons with MDR-TB who were aged 15–78 years (mean 36.4 ± 15.4 years). Of these, 40 (40.8 %) were cured, 25 (25.5 %) completed TB treatment, 1 (1.0 %) had treatment failure, 13 (13.3 %) died, and 19 (19.4 %) were lost to follow-up. Overall, 33 (33.7 %) participants had unsuccessful TB treatment which was associated with older age for a 1-year increase in age (aOR 1.05, 95 % CI 1.01–1.09), malnutrition—mid-upper arm circumference of &lt;12.5 cm (aOR 2.99, 95 % CI 1.16–7.98), and previous TB treatment (aOR 0.28, 95 % CI 0.10–0.77).</p></div><div><h3>Conclusion</h3><p>Unsuccessful TB treatment is high among persons with MDR-TB at this TB Unit. It is more likely as age advances and when persons with MDR-TB have malnutrition, but less likely when they have been previously treated for TB. Therefore, interventions to improve treatment outcomes may be beneficial for persons with MDR-TB who are older, malnourished, and those newly diagnosed with the disease. For example, routine nutritional assessment and counseling, including nutritional support for malnourished persons with MDR-TB may be needed to optimize their TB treatment success.</p></div>","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"37 ","pages":"Article 100477"},"PeriodicalIF":1.9,"publicationDate":"2024-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2405579424000640/pdfft?md5=dbc35999a5e1d0abc3b0e457d0979b7d&pid=1-s2.0-S2405579424000640-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141984695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advanced pulmonary tuberculosis in Alameda County: Ten-year incidence and risk factors 阿拉米达县的晚期肺结核:十年发病率和风险因素
IF 1.9 Q3 INFECTIOUS DISEASES Pub Date : 2024-08-05 DOI: 10.1016/j.jctube.2024.100475
Rachel Marusinec , Tessa Clifton , Amit S. Chitnis , Devan Jaganath

Background

Advanced pulmonary tuberculosis (APT) may reflect delays in tuberculosis (TB) diagnosis and contribute to ongoing disease transmission and poor outcomes. We characterized trends and factors associated with APT over ten years in a high TB-burden county within the United States.

Methods

We evaluated microbiologically and clinically confirmed TB cases reported to the Alameda County Public Health Department during 2010–2019. APT was defined as the presence of cavitation on chest imaging and positive acid-fast bacilli sputum smear. Over the ten-year period, we determined overall incidence and annual trends, and conducted multivariable logistic regression to identify sociodemographic and clinical factors associated with APT.

Results

We included 997 cases with pulmonary TB, of which 128 (12.8 %) had APT. The 10-year incidence of APT was 8.8 cases per 100,000, with no significant change in proportion over time. The median age of cases with APT were 50 years (IQR 32–61), 68 % were male, and 78.9 % were non-US-born. On multivariable assessment, APT cases were more likely than non-APT cases to use drugs in the past year (aOR 2.43, 95 % CI 1.10–35.09), to have diabetes (aOR 2.51, 95 % CI: 1.59–3.96), and be HIV negative (aOR 9.32 versus HIV positive, 95 % CI 1.87–169.77). While US nativity was not significantly associated with APT, it was an effect modifier. In stratified analysis, APT was more likely among those with drug-use in the last year among US-born, while diabetes was associated with APT among non-US-born individuals.

Conclusions

APT remains a substantial proportion of TB cases. Efforts to increase awareness and access to care are needed for key risk groups including those with recent drug use or diabetes, with consideration of cultural and linguistic factors given differences by US nativity.

背景晚期肺结核(APT)可能反映了结核病(TB)诊断的延误,并导致疾病的持续传播和不良后果。方法我们评估了 2010-2019 年间向阿拉米达县公共卫生局报告的微生物和临床确诊肺结核病例。APT的定义是胸部成像出现空洞和痰涂片酸性耐酸杆菌阳性。在这十年间,我们确定了总体发病率和年度趋势,并进行了多变量逻辑回归,以确定与 APT 相关的社会人口和临床因素。APT 的 10 年发病率为 8.8 例/100,000,随着时间的推移比例没有显著变化。APT 病例的中位年龄为 50 岁(IQR 32-61),68% 为男性,78.9% 非美国出生。在多变量评估中,APT 病例比非 APT 病例更有可能在过去一年中吸毒(aOR 2.43,95 % CI 1.10-35.09)、患有糖尿病(aOR 2.51,95 % CI:1.59-3.96)和 HIV 阴性(aOR 9.32 对 HIV 阳性,95 % CI 1.87-169.77)。虽然美国本土血统与 APT 的关系不大,但它是一个效应调节因子。在分层分析中,在美国出生的人中,去年使用过毒品的人更有可能感染 APT,而在非美国出生的人中,糖尿病与 APT 相关。需要努力提高主要风险人群(包括近期使用过毒品或患有糖尿病的人群)对结核病的认识并增加其获得治疗的机会,同时考虑到美国本土文化和语言因素的差异。
{"title":"Advanced pulmonary tuberculosis in Alameda County: Ten-year incidence and risk factors","authors":"Rachel Marusinec ,&nbsp;Tessa Clifton ,&nbsp;Amit S. Chitnis ,&nbsp;Devan Jaganath","doi":"10.1016/j.jctube.2024.100475","DOIUrl":"10.1016/j.jctube.2024.100475","url":null,"abstract":"<div><h3>Background</h3><p>Advanced pulmonary tuberculosis (APT) may reflect delays in tuberculosis (TB) diagnosis and contribute to ongoing disease transmission and poor outcomes. We characterized trends and factors associated with APT over ten years in a high TB-burden county within the United States.</p></div><div><h3>Methods</h3><p>We evaluated microbiologically and clinically confirmed TB cases reported to the Alameda County Public Health Department during 2010–2019. APT was defined as the presence of cavitation on chest imaging and positive acid-fast bacilli sputum smear. Over the ten-year period, we determined overall incidence and annual trends, and conducted multivariable logistic regression to identify sociodemographic and clinical factors associated with APT.</p></div><div><h3>Results</h3><p>We included 997 cases with pulmonary TB, of which 128 (12.8 %) had APT. The 10-year incidence of APT was 8.8 cases per 100,000, with no significant change in proportion over time. The median age of cases with APT were 50 years (IQR 32–61), 68 % were male, and 78.9 % were non-US-born. On multivariable assessment, APT cases were more likely than non-APT cases to use drugs in the past year (aOR 2.43, 95 % CI 1.10–35.09), to have diabetes (aOR 2.51, 95 % CI: 1.59–3.96), and be HIV negative (aOR 9.32 versus HIV positive, 95 % CI 1.87–169.77). While US nativity was not significantly associated with APT, it was an effect modifier. In stratified analysis, APT was more likely among those with drug-use in the last year among US-born, while diabetes was associated with APT among non-US-born individuals.</p></div><div><h3>Conclusions</h3><p>APT remains a substantial proportion of TB cases. Efforts to increase awareness and access to care are needed for key risk groups including those with recent drug use or diabetes, with consideration of cultural and linguistic factors given differences by US nativity.</p></div>","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"37 ","pages":"Article 100475"},"PeriodicalIF":1.9,"publicationDate":"2024-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2405579424000627/pdfft?md5=935412d46d636ba3f6a985d0866e9f0b&pid=1-s2.0-S2405579424000627-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141963859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors associated with tuberculosis drug resistance among presumptive multidrug resistance tuberculosis patients identified in a DRTB surveillance study in western Kenya 肯尼亚西部一项 DRTB 监测研究中发现的推定耐多药结核病患者中与结核病耐药性相关的因素
IF 1.9 Q3 INFECTIOUS DISEASES Pub Date : 2024-08-02 DOI: 10.1016/j.jctube.2024.100466
Albert Okumu , James Orwa , Ruth Sitati , Isaiah Omondi , Ben Odhiambo , Jeremiah Ogoro , George Oballa , Benjamin Ochieng , Steve Wandiga , Collins Ouma

Multidrug-resistant tuberculosis (MDR-TB) is caused by M. tuberculosis (Mtb) with resistance to the first-line anti-TB medicines isoniazid (INH) and rifampicin (RIF). In Western Kenya, there is reported low prevalence of drug resistant strains among HIV tuberculosis patients, creating a need to determine factors associated with drug resistance patterns among presumptive MDR-TB patients. To determine factors associated with drug resistance patterns among presumptive MDR-TB patients in western Kenya. Three hundred and ninety (3 9 0) sputum sample isolates from among presumptive multidrug TB patients, were analyzed for TB drug resistance as per Ministry of Health (MoH) TB program diagnostic algorithm. Frequency and percentages were used to summarize categorical data while median and interquartile range (IQR) were used for continuous data. Multivariable logistic regression was carried out to identify factors associated with TB drug resistance. Out of 390 participants enrolled, 302/390 (77.4 %) were males, with a median age of 34 years. The HIV-infected were 118/390 (30.3 %). Samples included 322 (82.6 %) from presumptive patients, while 68/390 (17.4 %) were either lost to follow-up patients, failures to first-line treatment or newly diagnosed cases. A total of 64/390 (16.4 %) of the isolates had at least some form of drug resistance. Out of 390, 14/390 (3.6 %) had MDR, 12 (3.1 %) were RIF mono-resistance, 34 (8.7 %) had INH, while 4 (1 %) had ethambutol resistance. The category of previously treated patients (those who received or are currently on TB treatment) had a 70 % reduced likelihood of resistance (aOR: 0.30; 95 % CI: 0.13–0.70). In contrast, older age was associated with an increased likelihood of resistance to INH and RIF, with an adjusted odds ratio of 1.04 per year (95 % CI: 1.00–1.08). Prompt MDR-TB diagnosis is essential for appropriate patient care, management, and disease prevention and control. We recommend active surveillance on drug resistant TB in these regions to detect drug resistance patterns for rapid disease management.

耐多药结核病(MDR-TB)是由对一线抗结核药物异烟肼(INH)和利福平(RIF)产生耐药性的结核杆菌(Mtb)引起的。据报道,在肯尼亚西部,艾滋病毒结核病患者中耐药菌株的发病率较低,因此有必要确定与推定耐药结核病患者耐药模式相关的因素。确定与肯尼亚西部推定 MDR-TB 患者耐药模式相关的因素。根据卫生部(MoH)结核病计划诊断算法,对来自推定多药肺结核患者的 390 (3 9 0) 份痰样本分离物进行了结核病耐药性分析。分类数据采用频率和百分比进行汇总,连续数据采用中位数和四分位数间距(IQR)进行汇总。为确定与结核病耐药性相关的因素,进行了多变量逻辑回归。在登记的 390 名参与者中,302/390(77.4%)为男性,年龄中位数为 34 岁。艾滋病毒感染者为 118 人/390 人(30.3%)。样本中有 322 份(82.6%)来自推定患者,68/390 份(17.4%)来自失去随访的患者、一线治疗失败者或新诊断病例。64/390(16.4%)个分离株至少具有某种形式的耐药性。在 390 个分离株中,有 14 个(3.6%)具有 MDR,12 个(3.1%)对 RIF 单耐药,34 个(8.7%)对 INH 耐药,4 个(1%)对乙胺丁醇耐药。曾接受过治疗的患者(接受过或正在接受结核病治疗的患者)出现耐药性的可能性降低了 70%(aOR:0.30;95 % CI:0.13-0.70)。相比之下,年龄越大,对 INH 和 RIF 产生耐药性的可能性就越大,调整后的几率比为每年 1.04(95 % CI:1.00-1.08)。及时诊断 MDR-TB 对适当的患者护理、管理和疾病防控至关重要。我们建议在这些地区对耐药结核病进行积极监测,以发现耐药模式,从而快速管理疾病。
{"title":"Factors associated with tuberculosis drug resistance among presumptive multidrug resistance tuberculosis patients identified in a DRTB surveillance study in western Kenya","authors":"Albert Okumu ,&nbsp;James Orwa ,&nbsp;Ruth Sitati ,&nbsp;Isaiah Omondi ,&nbsp;Ben Odhiambo ,&nbsp;Jeremiah Ogoro ,&nbsp;George Oballa ,&nbsp;Benjamin Ochieng ,&nbsp;Steve Wandiga ,&nbsp;Collins Ouma","doi":"10.1016/j.jctube.2024.100466","DOIUrl":"10.1016/j.jctube.2024.100466","url":null,"abstract":"<div><p>Multidrug-resistant tuberculosis (MDR-TB) is caused by <em>M. tuberculosis</em> (<em>Mtb</em>) with resistance to the first-line anti-TB medicines isoniazid (INH) and rifampicin (RIF). In Western Kenya, there is reported low prevalence of drug resistant strains among HIV tuberculosis patients, creating a need to determine factors associated with drug resistance patterns among presumptive MDR-TB patients. To determine factors associated with drug resistance patterns among presumptive MDR-TB patients in western Kenya. Three hundred and ninety (3<!--> <!-->9<!--> <!-->0) sputum sample isolates from among presumptive multidrug TB patients, were analyzed for TB drug resistance as per Ministry of Health (MoH) TB program diagnostic algorithm. Frequency and percentages were used to summarize categorical data while median and interquartile range (IQR) were used for continuous data. Multivariable logistic regression was carried out to identify factors associated with TB drug resistance. Out of 390 participants enrolled, 302/390 (77.4 %) were males, with a median age of 34 years. The HIV-infected were 118/390 (30.3 %). Samples included 322 (82.6 %) from presumptive patients, while 68/390 (17.4 %) were either lost to follow-up patients, failures to first-line treatment or newly diagnosed cases. A total of 64/390 (16.4 %) of the isolates had at least some form of drug resistance. Out of 390, 14/390 (3.6 %) had MDR, 12 (3.1 %) were RIF mono-resistance, 34 (8.7 %) had INH, while 4 (1 %) had ethambutol resistance. The category of previously treated patients (those who received or are currently on TB treatment) had a 70 % reduced likelihood of resistance (aOR: 0.30; 95 % CI: 0.13–0.70). In contrast, older age was associated with an increased likelihood of resistance to INH and RIF, with an adjusted odds ratio of 1.04 per year (95 % CI: 1.00–1.08). Prompt MDR-TB diagnosis is essential for appropriate patient care, management, and disease prevention and control. We recommend active surveillance on drug resistant TB in these regions to detect drug resistance patterns for rapid disease management.</p></div>","PeriodicalId":37942,"journal":{"name":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","volume":"37 ","pages":"Article 100466"},"PeriodicalIF":1.9,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2405579424000536/pdfft?md5=7b2b02de9f953b8195ed23b9e43f47c3&pid=1-s2.0-S2405579424000536-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141952249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1